Moderna Inc. buy Amped
Start price
29.11.21
/
0%
€319.25
Target price
29.11.22
-
Performance (%)
-47.84%
End price
30.11.22
€166.52
Summary
This prediction ended on 30.11.22 with a price of €166.52. The BUY prediction by Amped for Moderna Inc. performed very badly with a performance of -47.84%. This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Moderna Inc. | -9.635% | -9.635% | -31.847% |
iShares Core DAX® | 1.937% | 1.473% | 18.596% |
iShares Nasdaq 100 | -1.186% | -0.040% | 27.123% |
iShares Nikkei 225® | 1.938% | 4.205% | 17.502% |
iShares S&P 500 | -0.023% | 0.109% | 24.843% |
According to Amped what are the pros and cons of Moderna Inc. for the foreseeable future?
Pros
Fair valuation
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Standard Investments for future growth
positive Cash Flow expected
Capable Management
Medium risks for its business
Some uniques
Top 10 in its market
Known brand
Very Future proof/growth oriented business model
Cons
Sustainability is little important
Bad culture
Significant cyclical dependencies
Comments by Amped for this prediction
In the thread Moderna Inc. diskutieren
Buy Moderna Inc.
In the thread Trading Moderna Inc.
Die von Amped gewählte maximale Laufzeit wurde überschritten